共 34 条
DSM-5 pathological personality domains as vulnerability factors in predicting COVID-19-related anxiety symptoms
被引:11
|作者:
Zemestani, Mehdi
[1
]
Babamiri, Mohammad
[2
]
Griffiths, Mark D.
[3
]
Didehban, Reza
[1
]
机构:
[1] Univ Kurdistan, Dept Psychol, Sanandaj, Iran
[2] Hamadan Univ Med Sci, Hlth Sci Res Ctr, Sch Publ Hlth, Dept Ergon, Hamadan, Iran
[3] Nottingham Trent Univ, Psychol Dept, Nottingham, England
关键词:
DSM-5;
pathological personality traits;
anxiety;
COVID-19;
D O I:
10.1080/10550887.2021.1889752
中图分类号:
R194 [卫生标准、卫生检查、医药管理];
学科分类号:
摘要:
Since the beginning of the coronavirus disease-2019 (COVID-19) outbreak, individuals worldwide have shown different anxiety-related reactions. Several vulnerability factors may play a role in individuals' psychological reactions to the COVID-19 pandemic. Such factors include pathological personality traits which have been shown to contribute to the development of anxiety-related conditions. Consequently, the present study investigated the relationships between DSM-5 pathological personality domains and COVID-19-related anxiety symptoms. Using an online data portal, the relationships between DSM-5 pathological personality domains and COVID-19-related anxiety symptoms among a mixed university student and community sample (N = 612) were studied. The results showed that there was a positive and significant relationship between all DSM-5 pathological personality domains and COVID-19-related anxiety. The results of multiple linear regression analysis showed that DSM-5 pathological personality domains explained 21% of COVID-19-related anxiety variance. Based on standardized coefficients, the Personality Inventory for DSM-5 (PID-5) negative affect domain had the main role in COVID-19-related anxiety. The findings suggest that pathological personality domains can be predictors in the symptoms of anxiety in a viral outbreak. The novel findings add to the literature on individual differences in domains of personality in response to pandemic situations. Implications for future clinical applications and research investigations are discussed.
引用
收藏
页码:450 / 458
页数:9
相关论文